Vivimed Labs receives RTA report on physical share transfer re-lodgement requests
Vivimed Labs received a report from its RTA on re-lodgement requests for physical shares, as per SEBI circular. The report showed NIL requests received or processed as of September 2025.
This is a standard regulatory filing providing an update on a specific compliance requirement. The absence of any reported activity means there is no material impact on the company's operations, finances, or stock price.
The announcement is a routine compliance disclosure regarding physical share transfer requests. The report indicates no activity (NIL requests received, processed, approved, or rejected), which does not present any positive or negative implications for the company.
Vivimed Labs Limited announced on October 7, 2025, the receipt of a report from its Registrar and Share Transfer Agent (RTA), Aarthi Consultants Pvt Ltd, concerning the status of re-lodgement requests for physical shares. This intimation is in accordance with SEBI Circular No. SEBIIHO/MIRSDIMIRSD-PoD/P/CIRl2025/97 dated July 2, 2025. * The RTA's report, dated October 6, 2025, provides the status as of September 2025. * During the month of September 2025, the RTA reported: * No. of requests received: NIL * No. of requests processed: NIL * No. of requests approved: NIL * No. of requests rejected: NIL * Average time taken for processing of requests: NA This update is for the information and records of the stock exchanges.
What to do with a filing like this
Vivimed Labs Limited filed this with the NSE as a statutory disclosure, categorised under share transfer updates. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Vivimed Labs Limited. Read the original for the full detail.